Curiously, the latter included both poor-prognosis factors (younger age, ductal type, PAM50 luminal B subtype, and pathological node-positive status), and good-prognosis factors (lower tumor grade, ER+ status, PR+ status, HR+/HER2− status, and PAM50 luminal A subtype). This evidence concerns the gene PGR and neoplasm.